CORRELATION OF SUSCEPTIBILITY TEST-RESULTS INVITRO WITH RESPONSE INVIVO - KETOCONAZOLE THERAPY IN A SYSTEMIC CANDIDIASIS MODEL

被引：25

作者：

POLAK, A

ODDS, FC

LUDIN, E

SCHOLER, HJ

机构：

[1] F HOFFMANN LA ROCHE & CO LTD,DEPT ELECTR DATA PROC,CH-4002 BASEL,SWITZERLAND

[2] UNIV LEICESTER,DEPT MICROBIOL,LEICESTER LE1 7RH,ENGLAND

来源：

关键词：

D O I：

10.1159/000238365

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：395 / 404

页数：10

共 14 条

[1] AUGER P, 1984, MYKOSEN, V27, P498
[2] DROUHET E, 1973, B SOC FRANC MYCOL ME, V2, P135
[3] ANTIMICROBIAL SUSCEPTIBILITY TESTING OF YEASTS - TURBIDIMETRIC TECHNIQUE INDEPENDENT OF INOCULUM SIZE
GALGIANI, JN
STEVENS, DA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (04) : 721 - 726
[4] HALLER I, 1979, MYKOSEN, V22, P423
[5] ACTIVITY INVITRO AND INVIVO OF A NEW IMIDAZOLE ANTIFUNGAL, KETOCONAZOLE
ODDS, FC
MILNE, LJR
GENTLES, JC
BALL, EH
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (01) : 97 - &
[6] ODDS FC, 1983, J ANTIMICROB CHEMOTH, V12, P83
[7] PLEMPEL M, 1973, MYKOSEN, V27, P7
[8] MODE OF ACTION OF 5-FLUOROCYTOSINE AND MECHANISMS OF RESISTANCE
POLAK, A
SCHOLER, HJ
[J]. CHEMOTHERAPY, 1975, 21 (3-4) : 113 - 130
[9] POLAK A, 1982, ARZNEIMITTEL-FORSCH, V32-1, P17
[10] RYLEY JF, 1984, SABOURAUDIA, V22, P53